RenovoRx, Inc. (RNXT)

RenovoRx Statistics

Total Valuation

RenovoRx has a market cap or net worth of $35.52 million. The enterprise value is $28.65 million.

Market Cap	35.52M
Enterprise Value	28.65M

Important Dates

The next estimated earnings date is Friday, May 9, 2025, before market open.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

RenovoRx has 36.55 million shares outstanding. The number of shares has increased by 116.42% in one year.

Current Share Class	36.55M
Shares Outstanding	36.55M
Shares Change (YoY)	+116.42%
Shares Change (QoQ)	+0.67%
Owned by Insiders (%)	4.31%
Owned by Institutions (%)	2.80%
Float	34.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	826.13
Forward PS	n/a
PB Ratio	5.22
P/TBV Ratio	7.93
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	666.22
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.10, with a Debt / Equity ratio of 0.06.

Current Ratio	4.10
Quick Ratio	3.77
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -1,192.69% and return on invested capital (ROIC) is -780.89%.

Return on Equity (ROE)	-1,192.69%
Return on Assets (ROA)	-143.08%
Return on Invested Capital (ROIC)	-780.89%
Return on Capital Employed (ROCE)	-176.68%
Revenue Per Employee	$4,300
Profits Per Employee	-$881,400
Employee Count	10
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.80% in the last 52 weeks. The beta is 1.11, so RenovoRx's price volatility has been higher than the market average.

Beta (5Y)	1.11
52-Week Price Change	-21.80%
50-Day Moving Average	0.96
200-Day Moving Average	1.12
Relative Strength Index (RSI)	51.75
Average Volume (20 Days)	119,718

Short Selling Information

The latest short interest is 295,074, so 0.81% of the outstanding shares have been sold short.

Short Interest	295,074
Short Previous Month	263,207
Short % of Shares Out	0.81%
Short % of Float	0.84%
Short Ratio (days to cover)	2.76

Income Statement

In the last 12 months, RenovoRx had revenue of $43,000 and -$8.81 million in losses. Loss per share was -$0.40.

Revenue	43,000
Gross Profit	43,000
Operating Income	-10.97M
Pretax Income	-8.05M
Net Income	-8.81M
EBITDA	n/a
EBIT	-10.97M
Loss Per Share	-$0.40

Balance Sheet

The company has $7.15 million in cash and $278,000 in debt, giving a net cash position of $6.88 million or $0.19 per share.

Cash & Cash Equivalents	7.15M
Total Debt	278,000
Net Cash	6.88M
Net Cash Per Share	$0.19
Equity (Book Value)	4.48M
Book Value Per Share	0.19
Working Capital	5.92M

Cash Flow

In the last 12 months, operating cash flow was -$9.13 million and capital expenditures -$12,000, giving a free cash flow of -$9.14 million.

Operating Cash Flow	-9.13M
Capital Expenditures	-12,000
Free Cash Flow	-9.14M
FCF Per Share	-$0.25

Margins

Gross Margin	100.00%
Operating Margin	-25,511.63%
Pretax Margin	-20,497.67%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RenovoRx does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-116.42%
Shareholder Yield	-116.42%
Earnings Yield	-24.81%
FCF Yield	-25.72%

Analyst Forecast

The average price target for RenovoRx is $7.00, which is 620.17% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.00
Price Target Difference	620.17%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	397.27%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

RenovoRx has an Altman Z-Score of -7.94 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-7.94
Piotroski F-Score	1